New NICE recommended migraine pill to help 170k patients
Migraine affects a total of 4.5 million people in the UKÂ Â
Patients suffering from chronic and episodic migraine attacks are set to benefit from a...
Acute migraine? NICE recommends Pfizer’s rimegepant as potential option
The National Institute for Health and Care Excellence (NICE) has released conclusive draft guidance, suggesting Pfizer's Vydura (rimegepant) as a choice for treating acute...